Source:http://linkedlifedata.com/resource/pubmed/id/11005049
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-2-2
|
pubmed:abstractText |
Six factorially designed studies evaluated the effects of different schedules of electroconvulsive shocks (ECSs) on alpha-2 adrenoceptor function in the rat brain. Attenuation of the hypomotility response to a clonidine challenge was taken to indicate alpha-2 adrenoceptor downregulation, a putative mediator of antidepressant action. Six daily and six alternate-day ECSs were shown separately to produce this receptor change. Three alternate-day ECSs produced comparable downregulation for a comparable period as six daily ECSs; this suggests that ECS produces time-dependent effects. No changes were elicited with a single ECS, which indicates that a single ECS may not influence alpha-2 receptor function. Three daily ECSs produced brief downregulation, which has implications for receptor dynamics as a function of the ECS schedule. Finally, maintenance ECSs sustained alpha-2 adrenoceptor downregulation over 6 weeks, which suggests a possible neurochemical basis for maintenance electroconvulsive therapy. The clinical relevance and scope for further research are discussed.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1095-0680
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
268-78
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11005049-Adrenergic alpha-Agonists,
pubmed-meshheading:11005049-Animals,
pubmed-meshheading:11005049-Clonidine,
pubmed-meshheading:11005049-Down-Regulation,
pubmed-meshheading:11005049-Electroconvulsive Therapy,
pubmed-meshheading:11005049-Male,
pubmed-meshheading:11005049-Motor Activity,
pubmed-meshheading:11005049-Rats,
pubmed-meshheading:11005049-Rats, Sprague-Dawley,
pubmed-meshheading:11005049-Receptors, Adrenergic, alpha-2
|
pubmed:year |
2000
|
pubmed:articleTitle |
Electroconvulsive therapy and the alpha-2 noradrenergic receptor: implications of treatment schedule effects.
|
pubmed:affiliation |
Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. candrade@bgl.vsnl.net.in
|
pubmed:publicationType |
Journal Article
|